-transparent.png){kind=logo}
Increased levels of platelet-derived growth factor (PDGF) may play a central role in the development of arteriosclerosis, but the factors that inhibit PDGF production in vascular endothelial cells remain mostly unknown. We examined the effects of cilostazol, an antithrombotic agent, and high glucose on PDGF production in cultured human umbilical vein endothelial cells (HUVEC). HUVEC grown in high glucose exhibits increased PDGF production, which was markedly inhibited by cilostazol. Since cilostazol inhibits PDGF production in HUVEC, its use may exhibit anti-arteriosclerotic effects in diabetic patients.
Related Publications
M Mizutani, and
Y Okuda, and
K Yamashita
August 1989,
The American journal of physiology,
M Mizutani, and
Y Okuda, and
K Yamashita
January 1987,
The American journal of pathology,
M Mizutani, and
Y Okuda, and
K Yamashita
June 1995,
Magnesium research,
M Mizutani, and
Y Okuda, and
K Yamashita
February 2011,
Molecular biology reports,
M Mizutani, and
Y Okuda, and
K Yamashita
June 1989,
Experimental eye research,
M Mizutani, and
Y Okuda, and
K Yamashita
May 2008,
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
M Mizutani, and
Y Okuda, and
K Yamashita
April 1988,
Thrombosis and haemostasis,
M Mizutani, and
Y Okuda, and
K Yamashita
April 1989,
Endocrinology,
M Mizutani, and
Y Okuda, and
K Yamashita
June 2005,
Growth factors (Chur, Switzerland),
M Mizutani, and
Y Okuda, and
K Yamashita
April 1998,
Biochemical and biophysical research communications,
